(Q34644636)

English

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

based on heuristic

inferred from title

budesonide/formoterol

1 reference

based on heuristic

inferred from title

Anna Bodzenta-Lukaszyk

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Roland Buhl

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Beatrix Balint

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Mark Lomax

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Kay Spooner

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sanjeeva Dissanayake

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

0 references

publication date

26 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Journal of Asthma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1060-1070

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Recent advances in the pathophysiology of asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

The costs of asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Scientific rationale for using a single inhaler for asthma control

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Poor control increases the economic cost of asthma. A multicentre population-based study.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Asthma control in Europe: a real-world evaluation based on an international population-based study.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Update on asthma control in five European countries: results of a 2008 survey.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

The use of inhaled formoterol in the treatment of asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Systematic review and meta-analysis of budesonide/formoterol in a single inhaler

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Lung function and asthma control with beclomethasone and formoterol in a single inhaler

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.719253

21 January 2018

Identifiers

10.3109/02770903.2012.719253

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23102189%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34644636&oldid=1966807040"